Cancer Research Versailles No Abst  Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kadekaro, A. L.
Right arrow Articles by Abdel-Malek, Z. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kadekaro, A. L.
Right arrow Articles by Abdel-Malek, Z. A.
[Cancer Research 65, 4292-4299, May 15, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

{alpha}-Melanocortin and Endothelin-1 Activate Antiapoptotic Pathways and Reduce DNA Damage in Human Melanocytes

Ana Luisa Kadekaro1, Renny Kavanagh1, Hiromi Kanto1, Silva Terzieva1, Jennifer Hauser2, Nobuhiko Kobayashi4, Sandy Schwemberger3, James Cornelius3, George Babcock3, Howard G. Shertzer2, Glynis Scott5 and Zalfa A. Abdel-Malek1

Departments of 1 Dermatology, 2 Environmental Health, and 3 Surgery, University of Cincinnati College of Medicine and Shriners' Burns Institute, Cincinnati, Ohio; 4 Department of Dermatology, Nara Medical University, Nara, Japan; and 5 Department of Dermatology, University of Rochester, Rochester, New York

Requests for reprints: Zalfa A. Abdel-Malek, Department of Dermatology, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267-0592. Phone: 513-558-6242; Fax: 513-558-0198; E-mail: abdelmza{at}email.uc.edu.

UV radiation is an important etiologic factor for skin cancer, including melanoma. Constitutive pigmentation and the ability to tan are considered the main photoprotective mechanism against sun-induced carcinogenesis. Pigmentation in the skin is conferred by epidermal melanocytes that synthesize and transfer melanin to keratinocytes. Therefore, insuring the survival and genomic stability of epidermal melanocytes is critical for inhibiting photocarcinogenesis, particularly melanoma, the most deadly form of skin cancer. The paracrine factors {alpha}-melanocortin and endothelin-1 are critical for the melanogenic response of cultured human melanocytes to UV radiation. We report that {alpha}-melanocortin and endothelin-1 rescued human melanocytes from UV radiation–induced apoptosis and reduced DNA photoproducts and oxidative stress. The survival effects of {alpha}-melanocortin and endothelin-1 were mediated by activation of the melanocortin 1 and endothelin receptors, respectively. Treatment of melanocytes with {alpha}-melanocortin and/or endothelin-1 before exposure to UV radiation activated the inositol triphosphate kinase-Akt pathway and increased the phosphorylation and expression of the microphthalmia-related transcription factor. Treatment with {alpha}-melanocortin and/or endothelin-1 enhanced the repair of cyclobutane pyrimidine dimers and reduced the levels of hydrogen peroxide induced by UV radiation. These effects are expected to reduce genomic instability and mutagenesis.




This article has been cited by other articles:


Home page
EndocrinologyHome page
A. Kokot, D. Metze, N. Mouchet, M.-D. Galibert, M. Schiller, T. A. Luger, and M. Bohm
{alpha}-Melanocyte-Stimulating Hormone Counteracts the Suppressive Effect of UVB on Nrf2 and Nrf-Dependent Gene Expression in Human Skin
Endocrinology, July 1, 2009; 150(7): 3197 - 3206.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Le Pape, T. Passeron, A. Giubellino, J. C. Valencia, R. Wolber, and V. J. Hearing
Microarray analysis sheds light on the dedifferentiating role of agouti signal protein in murine melanocytes via the Mc1r
PNAS, February 10, 2009; 106(6): 1802 - 1807.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
T. Brzoska, T. A. Luger, C. Maaser, C. Abels, and M. Bohm
{alpha}-Melanocyte-Stimulating Hormone and Related Tripeptides: Biochemistry, Antiinflammatory and Protective Effects in Vitro and in Vivo, and Future Perspectives for the Treatment of Immune-Mediated Inflammatory Diseases
Endocr. Rev., August 1, 2008; 29(5): 581 - 602.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. G. Smith, N. Luk, R. A. Newton, D. W. Roberts, R. A. Sturm, and G. E. O. Muscat
Melanocortin-1 Receptor Signaling Markedly Induces the Expression of the NR4A Nuclear Receptor Subgroup in Melanocytic Cells
J. Biol. Chem., May 2, 2008; 283(18): 12564 - 12570.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. B. Lesinski, J. Trefry, M. Brasdovich, S. V. Kondadasula, K. Sackey, J. M. Zimmerer, A. R. Chaudhury, L. Yu, X. Zhang, T. R. Crespin, et al.
Melanoma Cells Exhibit Variable Signal Transducer and Activator of Transcription 1 Phosphorylation and a Reduced Response to IFN-{alpha} Compared with Immune Effector Cells
Clin. Cancer Res., September 1, 2007; 13(17): 5010 - 5019.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
M J Grimshaw
Endothelins and hypoxia-inducible factor in cancer
Endocr. Relat. Cancer, June 1, 2007; 14(2): 233 - 244.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Spinella, L. Rosano, V. Di Castro, S. Decandia, M. R. Nicotra, P. G. Natali, and A. Bagnato
Endothelin-1 and Endothelin-3 Promote Invasive Behavior via Hypoxia-Inducible Factor-1{alpha} in Human Melanoma Cells
Cancer Res., February 15, 2007; 67(4): 1725 - 1734.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. L. Sanchez-Laorden, C. Jimenez-Cervantes, and J. C. Garcia-Borron
Regulation of Human Melanocortin 1 Receptor Signaling and Trafficking by Thr-308 and Ser-316 and Its Alteration in Variant Alleles Associated with Red Hair and Skin Cancer
J. Biol. Chem., February 2, 2007; 282(5): 3241 - 3251.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Manga, D. Sheyn, F. Yang, R. Sarangarajan, and R. E. Boissy
A Role for Tyrosinase-Related Protein 1 in 4-tert-Butylphenol-Induced Toxicity in Melanocytes: Implications for Vitiligo
Am. J. Pathol., November 1, 2006; 169(5): 1652 - 1662.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Z. A. Abdel-Malek, A. L. Kadekaro, R. J. Kavanagh, A. Todorovic, L. N. Koikov, J. C. McNulty, P. J. Jackson, G. L. Millhauser, S. Schwemberger, G. Babcock, et al.
Melanoma prevention strategy based on using tetrapeptide {alpha}-MSH analogs that protect human melanocytes from UV-induced DNA damage and cytotoxicity
FASEB J, July 1, 2006; 20(9): 1561 - 1563.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. Kauser, A. Slominski, E. T. Wei, and D. J. Tobin
Modulation of the human hair follicle pigmentary unit by corticotropin-releasing hormone and urocortin peptides
FASEB J, May 1, 2006; 20(7): 882 - 895.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. T. Landi, P. Kanetsky, A. Goldstein, and R. Pfeiffer
RESPONSE: Re: MC1R, ASIP, and DNA Repair in Sporadic and Familial Melanoma in a Mediterranean Population
J Natl Cancer Inst, January 18, 2006; 98(2): 145 - 146.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.